多灶性前列腺癌中最大体积与最高分级不重合病例的分级
在最大肿瘤为GG2且存在更高级别次要肿瘤的67例中,5年生化复发无生存率显著低于最大肿瘤为GG2的一致病例(76%和67% vs 91%),提示预后应由最高分级次要病灶决定。
要点
- 多灶性前列腺癌中约14.7%存在最大体积与最高分级不重合。
- 最大肿瘤为GG2但次要肿瘤为GG3或GG4/5时,5年无生化复发生存率分别为76%和67%。
- 此类不一致病例的预后显著差于最大肿瘤为GG2的一致病例(91%)。
核心结论
- 不一致病例的预后更好由具有最高GG的次要肿瘤病灶决定,而非最大体积病灶。
研究设计与样本
- 识别580例(85.3%)一致病例和100例(14.7%)不一致病例。
- 研究队列为67例最大肿瘤GG2且次要肿瘤GG更高者,对照队列为212例最大肿瘤GG2的一致病例。
主要发现
- 研究队列中48例(71.6%)次要肿瘤为GG3,19例(28.4%)为GG4/5。
- 研究队列5年生化复发无生存率分别为76%(次要GG3)和67%(次要GG4/5)。
- 对照队列5年生化复发无生存率为91%,显著优于研究队列(p=0.013和p=0.014)。
关键数值与推荐
- 不一致病例定义为最大肿瘤体积与最高GG不在同一病灶。
- 研究队列:最大肿瘤GG2且存在更高GG次要肿瘤。
- 对照队列:最大肿瘤为GG2的一致病例。
临床怎么用
- 对于多灶性前列腺癌,若最大病灶GG2但存在更高GG次要病灶,应按最高GG进行风险分层和管理。
- 报告病理时应明确标注最高GG病灶,避免仅依据最大病灶分级。
局限性
- 回顾性研究设计。
- 中位随访时间4.2年,相对较短。
- 研究队列样本量较小(67例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In general, the index lesion of prostate cancer has the largest tumor volume, the highest Grade Group (GG), and the highest stage (concordant cases). However, these factors sometimes do not coincide within one lesion (discordant cases). In such discordant cases, the largest tumor may not be of biological significance and the secondary tumor may more greatly impact the prognosis. MATERIALS AND METHODS: We retrospectively reviewed the medical records of patients who underwent radical prostatectomy, and we identified 580 (85.3%) concordant cases and 100 (14.7%) discordant cases. The end point of this study was biochemical recurrence, and median followup was 4.2 years. RESULTS: Among discordant cases in which GGs of the largest tumor and the highest GG tumor differed, the majority (67 patients) had the largest tumor of GG 2, and we set them as the study cohort. On the other hand, we regarded 212 concordant cases with an index tumor of GG 2 as the control cohort. The study cohort comprised 48 (71.6%) patients with a secondary tumor of GG 3 and 19 (28.4%) with a secondary tumor of GG 4/5. Kaplan-Meier curves revealed that the 5-year biochemical recurrence-free survival rates were 76%, and 67%, respectively. The 5-year biochemical recurrence-free survival rate of the control cohort was 91%, which was significantly better than that of the study cohort (p=0.013 and p=0.014, respectively). CONCLUSIONS: Our study suggests that the prognosis of discordant cases is better determined by the secondary cancer lesion with the highest GG instead of the largest lesion.
引用
- Matsumoto K, Omura M, Takeda T, et al. Grading of Multifocal Prostate Cancer Cases in which the Largest Volume and the Highest Grade Do Not Coincide within One Lesion. J Urol. 2021. PMID: 33818138. doi:10.1097/JU.0000000000001765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。